Aptose Biosciences Inc.·4

Mar 20, 2:19 PM ET

PLATZER ERICH 4

4 · Aptose Biosciences Inc. · Filed Mar 20, 2019

Insider Transaction Report

Form 4
Period: 2019-03-19
Transactions
  • Sale

    Common Shares

    2019-03-19$2.19/sh+15,000$32,835130,000 total
  • Sale

    Common Shares

    2019-03-19$2.19/sh+5,000$10,970135,000 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.18 to $2.19, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.18 to $2.20, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4